Randomised controlled trial of maintaining low serum ferritin levels in patients receiving darbepoetin (Aranesp®)
Completed
- Conditions
- HaemodialysisSurgery
- Registration Number
- ISRCTN89787518
- Lead Sponsor
- Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients will be drawn from the population of haemodialysis patients attending Leeds General Infirmary renal unit.
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Haemoglobin (g/dl), Darbepoetin (ug/kg/week), Serum Ferritin, Iron Dose (mg/kg/week). Transferrin saturation percentage. C-reactive protein.
- Secondary Outcome Measures
Name Time Method ot provided at time of registration